The term " Disreputable Pharma" has emerged recently, sparking a heated discussion surrounding some pharmaceutical companies . Allegations of misleading marketing tactics , unreasonable drug rates, and a apparent disregard for patient well-being have led to increasing criticism from authorities , pu